There are many types of liver disease — from alcoholic-related liver disease to haemochromatosis and hepatitis, to name just a few. These conditions can damage your liver, but managing your symptoms can help avoid complications. You can prevent many types of liver disease by following a healthy lifestyle and reducing the amount of alcohol you drink.
Liver disease includes several conditions that can damage your liver and its ability to function correctly. While the cause of each condition is different, they all damage your liver in a similar, progressive way.
If you want to check your liver health, you can do a liver blood test (formerly known as a liver function blood test or LFT) at home. It's important to note that this test can't diagnose or rule out liver disease on its own.
When doing this blood test, a GP will review your:
Some of the most common types of liver disease are:
Your liver can still function with some degree of damage, so you might not get any liver disease symptoms until the later stages. This is often once severe scarring (liver cirrhosis) and abnormal tissue have developed.
The most common liver disease symptoms include:
Most liver diseases have 4 stages, including:
End-stage liver disease is the most severe form of cirrhosis. It’s monitored using the Model for End-Stage Liver Disease (MELD) score.
The MELD score measures your:
There are many different types and causes of liver disease. Managing your weight and not having more than 14 units of alcohol a week (6 pints of beer or 10 small glasses of wine) can help prevent some of them.
Alcohol-related liver disease (ALRD)
ARLD is caused by excessive, long-term alcohol consumption. Most people who drink more than 40 g of alcohol (4 standard drinks) a day will develop stage 2 of liver disease — alcoholic steatohepatitis. But only 10-15% will go on to develop more severe stages of the disease.
Find out more about the effects of alcohol on your body.
Non-alcoholic fatty liver disease (NAFLD)
NAFLD is caused by fat build up in your liver. It’s linked to carrying excess weight and having insulin resistance — when your cells don’t respond properly to insulin, it causes your blood sugar levels to stay high. This is found in people with type 2 diabetes and often those with PCOS.
Hepatitis
Hepatitis can be viral, meaning it can be caused by an infectious virus — like hepatitis B or C. There’s also an autoimmune form of hepatitis, a chronic and progressive form of liver inflammation that has unknown causes.
Primary biliary cirrhosis (PBC)
PBC is an autoimmune disease that causes chronic inflammation of the bile ducts in your liver. It’s linked to problems with your immune system, but the exact cause is unknown (like many autoimmune conditions).
Liver disease treatment depends on what type of liver disease you have. It’s vital to stop or treat whatever is causing the damage to your liver. This will help slow down or stop the progress of the disease so your liver can begin to repair itself. So this could mean antiviral therapy for viral hepatitis or a liver transplant for very advanced and life-threatening stages of liver disease.
As well as stopping further damage to your liver, an essential part of treatment is to manage your liver disease symptoms to avoid complications.
Lifestyle changes
Lifestyle and dietary changes are essential for all types of liver disease treatment. Your liver is vital to digestion, detoxification, and metabolism. So when your liver is damaged, it’s best not to eat or drink anything that might make it worse.
These include:
Some types of liver disease treatment rely more on lifestyle changes than others. For example, dietary modifications are critical to the initial treatment phase of NAFLD. Aiming to reduce your weight by 4-10% can be beneficial, especially when combined with exercise and dietary changes.
Like the Mediterranean diet, eating a diet rich in vegetables, whole grains, and unsaturated fats can also improve insulin resistance and reduce fatty deposits in your liver.
Even though these are an essential part of NAFLD treatment, these lifestyle changes also help manage all liver diseases and slow their progression.
When liver disease progresses to advanced stages, lack of proper nutrition (malnourishment) and micronutrient deficiencies can become a concern.
At this point, your liver disease treatment might include:
The good news is that your liver is good at repairing itself. So if the underlying cause is treated, not only are symptoms managed, but the progress of the disease can slow down or stop. This means your liver might even regain some of its previously lost function.
There can be many serious liver disease complications depending on which type you have. That’s why acting quickly and getting the right treatment is vital.
Alcohol-related liver disease complications include:
Non-alcoholic liver disease complications include:
Brunner, K.T., Henneberg, C.J., Wilechansky, R.M. et al. Nonalcoholic Fatty Liver Disease and Obesity Treatment. Curr Obes Rep 8, 220–228 (2019). https://doi.org/10.1007/s13679-019-00345-1
Haberl, J., Zollner, G., Fickert, P., & Stadlbauer, V. (2018). To salt or not to salt?—That is the question in cirrhosis. Liver International, 38(7), 1148-1159.
Hajifathalian, K., Torabi Sagvand, B., & McCullough, A. J. (2019). Effect of alcohol consumption on survival in nonalcoholic fatty liver disease: a national prospective cohort study. Hepatology, 70(2), 511-521.
Jefferies, M., Rauff, B., Rashid, H., Lam, T., & Rafiq, S. (2018). Update on global epidemiology of viral hepatitis and preventive strategies. World journal of clinical cases, 6(13), 589.
Jia, G. Y., Han, T., Gao, L., Wang, L., Wang, S. C., Yang, L., ... & Di, F. S. (2018). Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi= Chinese journal of hepatology, 26(1), 34-41.
Kamath, P. S., & Kim, W. R. (2007). The model for end‐stage liver disease (MELD). Hepatology, 45(3), 797-805.
Krawitt, E. L. (2006). Autoimmune hepatitis. New England Journal of Medicine, 354(1), 54-66.
Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C. D., & Targher, G. (2020). Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism, 111, 154170.
Parker, R., Kim, S. J., Im, G. Y., Nahas, J., Dhesi, B., Vergis, N., ... & Gao, B. (2019). Obesity in acute alcoholic hepatitis increases morbidity and mortality. EBioMedicine, 45, 511-518.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 38(2), 485-521.
Portillo-Sanchez, P., Bril, F., Maximos, M., Lomonaco, R., Biernacki, D., Orsak, B., ... & Cusi, K. (2015). High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. The Journal of Clinical Endocrinology & Metabolism, 100(6), 2231-2238.
Public Health England. (2020). Liver disease: applying All Our Health. Retrieved from https://www.gov.uk/government/publications/liver-disease-applying-all-our-health/liver-disease-applying-all-our-health
Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., ... & Wilson, A. M. (2013). The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. Journal of hepatology, 59(1), 138-143.
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., ... & Tsukamoto, H. (2018). Alcoholic liver disease. Nature Reviews Disease Primers, 4(1), 1-22.
Selmi, C., Coppel, R. L., & Gershwin, M. E. (2006). Primary biliary cirrhosis. In The Autoimmune Diseases (pp. 749-765). Academic Press.
Thoma, C., Day, C. P., & Trenell, M. I. (2012). Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. Journal of hepatology, 56(1), 255-266.
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021). Dietary carbohydrates and fats in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology, 1-17.